GB0909435D0 - Nanoparticle for biomolecule delivery - Google Patents

Nanoparticle for biomolecule delivery

Info

Publication number
GB0909435D0
GB0909435D0 GBGB0909435.0A GB0909435A GB0909435D0 GB 0909435 D0 GB0909435 D0 GB 0909435D0 GB 0909435 A GB0909435 A GB 0909435A GB 0909435 D0 GB0909435 D0 GB 0909435D0
Authority
GB
United Kingdom
Prior art keywords
nanoparticle
biomolecule delivery
biomolecule
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0909435.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Strathclyde
Original Assignee
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Strathclyde filed Critical University of Strathclyde
Priority to GBGB0909435.0A priority Critical patent/GB0909435D0/en
Publication of GB0909435D0 publication Critical patent/GB0909435D0/en
Priority to PCT/GB2010/001070 priority patent/WO2010139942A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0909435.0A 2009-06-02 2009-06-02 Nanoparticle for biomolecule delivery Ceased GB0909435D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0909435.0A GB0909435D0 (en) 2009-06-02 2009-06-02 Nanoparticle for biomolecule delivery
PCT/GB2010/001070 WO2010139942A2 (en) 2009-06-02 2010-06-01 Nanoparticle for biomolecule delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0909435.0A GB0909435D0 (en) 2009-06-02 2009-06-02 Nanoparticle for biomolecule delivery

Publications (1)

Publication Number Publication Date
GB0909435D0 true GB0909435D0 (en) 2009-07-15

Family

ID=40902438

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0909435.0A Ceased GB0909435D0 (en) 2009-06-02 2009-06-02 Nanoparticle for biomolecule delivery

Country Status (2)

Country Link
GB (1) GB0909435D0 (en)
WO (1) WO2010139942A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9358310B2 (en) 2007-09-17 2016-06-07 The Curators Of The University Of Missouri EGCG stabilized gold nanoparticles and method for making same
WO2014071190A1 (en) * 2012-11-05 2014-05-08 The Curators Of The University Of Missouri Egcg stabilized gold nanoparticles and method for making same
CN107860912B (en) * 2017-11-08 2019-12-17 南方医科大学南方医院 Detection method of bifunctional aptamer-mediated A549 tumor cells
CZ309422B6 (en) * 2020-09-29 2022-12-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Surface modified particles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601331B2 (en) * 2004-11-10 2009-10-13 National University Of Singapore NIR-sensitive nanoparticle
US20060222595A1 (en) 2005-03-31 2006-10-05 Priyabrata Mukherjee Nanoparticles for therapeutic and diagnostic applications
EP2217063B1 (en) 2007-11-08 2014-12-17 Virginia Tech Intellectual Properties, Inc. Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents
SI2379114T1 (en) * 2008-12-16 2014-11-28 Fundacio Privada Institut Catala De Nanotecnologia Conjugates comprising nanoparticles coated with platinum containing compounds
CN101816797B (en) * 2010-02-12 2012-06-06 中国科学技术大学 Gold nanoparticles used as medicament carrier and method for preparing same

Also Published As

Publication number Publication date
WO2010139942A2 (en) 2010-12-09
WO2010139942A3 (en) 2011-06-16

Similar Documents

Publication Publication Date Title
EP2341897A4 (en) Nanoparticles for immunotherapy
GB201005601D0 (en) Ecapsulated nanoparticles
ZA201006260B (en) Delivery particle
ZA201005524B (en) Delivery particle
ZA201100622B (en) Delivery particle
IL214996A0 (en) Anti-bcma antibodies
PL2563508T3 (en) Delivery particle
GB0920127D0 (en) Antibodies
GB0909906D0 (en) Antibodies
GB0903810D0 (en) Delivery system
EP2427496A4 (en) Anti-vegf-d antibodies
HRP20141257T1 (en) Antibodies against her2 truncated variant ctf-611
GB0920324D0 (en) Antibodies
GB0902014D0 (en) SMS delivery technique
PL2228278T3 (en) Wagon
HK1170745A1 (en) Antibodies against il-17br il-17br
EP2398476A4 (en) Policosanol nanoparticles
GB0811170D0 (en) Nanoparticles
GB201006818D0 (en) Drug delivery
GB0909435D0 (en) Nanoparticle for biomolecule delivery
EP2499256A4 (en) Anti-c-mpl antibodies
GB2458967B (en) An improved delivery container
EP2424892A4 (en) Dc-stamp antibodies
GB0917792D0 (en) Delivery agent
EP2409764A4 (en) Nanoparticle loading method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)